In the treatment of hypercholesterolemia, the use of statins (e.g., simvastatin) increases FNDC5 mRNA expression and IR secretion both in vitro and in vivo, highlighting the potential cholesterol-lowering effects of IR [50]. The gene discussed is FNDC5; the disease is familial hypercholesterolemia.